UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficient precise in vivo base editing in adult dystrophic mice

Nature communications, 2021-06, Vol.12 (1), p.3719-14, Article 3719

2021

Volltextzugriff (PDF)

In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice

Circulation research, 2017-09, Vol.121 (8), p.923-929

2017

Volltextzugriff (PDF)

A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9

Disease models & mechanisms, 2018-06, Vol.11 (6)

2018

Volltextzugriff (PDF)

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non―Small Cell Lung Cancer

Clinical cancer research, 2013-11, Vol.19 (22), p.6183-6192

2013

Volltextzugriff (PDF)

Automated muscle histopathology analysis using CellProfiler

Skeletal muscle, 2018-10, Vol.8 (1), p.32-32, Article 32

2018

Volltextzugriff (PDF)

Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations

Cell death & disease, 2018-05, Vol.9 (6), p.609, Article 609

2018

Volltextzugriff (PDF)

Correction: Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations

Cell death & disease, 2020-06, Vol.11 (6), p.468-468, Article 468

2020

Volltextzugriff (PDF)

BVES is a novel interactor of ANO5 and regulates myoblast differentiation

Cell & bioscience, 2021-12, Vol.11 (1), p.222-222, Article 222

2021

Volltextzugriff (PDF)

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft- Versus -Host Disease

Frontiers in oncology, 2021-10, Vol.11, p.760789-760789

2021

Volltextzugriff (PDF)

Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA

Nucleic acids research, 2017-03, Vol.45 (5), p.e28

2017

Volltextzugriff (PDF)

BEON: A Functional Fluorescence Reporter for Quantification and Enrichment of Adenine Base-Editing Activity

Molecular therapy, 2020-07, Vol.28 (7), p.1696-1705

2020

Volltextzugriff (PDF)

Prohibitin Is a Substrate of PRMT5 in T Cells and Is a Potential Therapeutic Target for Acute Graft-Versus-Host Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.10229-10230

2022

Volltextzugriff (PDF)

Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice

Molecular therapy, 2019-08, Vol.27 (8), p.1407-1414

2019

Volltextzugriff (PDF)

CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice

Molecular therapy, 2016-03, Vol.24 (3), p.564-569

2016

Volltextzugriff (PDF)

Prohibitin is Upregulated on Donor T cells in Murine Acute Graft-versus-Host Disease and Promotes Th17 Response

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.173-173.13

2023

Volltextzugriff (PDF)

Bromodomain and Extraterminal (BET) Domain Inhibition with PLX51107 and PLX2853 Improves Survival and Decreases Acute GVHD Severity in Murine Models

Blood, 2019-11, Vol.134 (Supplement_1), p.4429-4429

2019

Volltextzugriff (PDF)

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Alleviates Chronic Graft- Versus-Host-Disease Via Modulating the CXCR5/CXCL13 Axis

Blood, 2023-11, Vol.142 (Supplement 1), p.2047-2047

2023

Volltextzugriff (PDF)

CRISPR/Cas9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

The Journal of immunology (1950), 2023-05, Vol.210 (1_Supplement), p.173-173.21

2023

Volltextzugriff (PDF)

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

Blood, 2022-11, Vol.140 (Supplement 1), p.10200-10201

2022

Volltextzugriff (PDF)

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Journal of visualized experiments, 2018-08 (138)

2018

Volltextzugriff (PDF)

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC

Cancer research (Chicago, Ill.), 2019-09, Vol.79 (17), p.4439-4452

2019

Volltextzugriff (PDF)

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Journal of visualized experiments, 2018-08 (138)

2018

Volltextzugriff (PDF)

PRMT5 promotes STAT-1 mediated T cell inflammatory response and is a therapeutic target for acute graft-versus-host disease

The Journal of immunology (1950), 2020-05, Vol.204 (1_Supplement), p.87-87.24

2020

Volltextzugriff (PDF)

20. A Novel Approach in the Treatment of Dystrophic Cardiomyopathy

Molecular therapy, 2016-05, Vol.24, p.S10-S10

2016

Volltextzugriff (PDF)

577. Empower Multiplex CRISPR-Mediated Gene Manipulation with Self-Cleaving Ribozymes and tRNA

Molecular therapy, 2016-05, Vol.24, p.S230-S230

2016

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(113)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficient precise in vivo base editing in adult dystrophic mice

In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice

A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non―Small Cell Lung Cancer

Automated muscle histopathology analysis using CellProfiler

Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations

Correction: Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations

BVES is a novel interactor of ANO5 and regulates myoblast differentiation

Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft- Versus -Host Disease

Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA

BEON: A Functional Fluorescence Reporter for Quantification and Enrichment of Adenine Base-Editing Activity

Prohibitin Is a Substrate of PRMT5 in T Cells and Is a Potential Therapeutic Target for Acute Graft-Versus-Host Disease

Life-Long AAV-Mediated CRISPR Genome Editing in Dystrophic Heart Improves Cardiomyopathy without Causing Serious Lesions in mdx Mice

CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice

Prohibitin is Upregulated on Donor T cells in Murine Acute Graft-versus-Host Disease and Promotes Th17 Response

Bromodomain and Extraterminal (BET) Domain Inhibition with PLX51107 and PLX2853 Improves Survival and Decreases Acute GVHD Severity in Murine Models

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins Alleviates Chronic Graft- Versus-Host-Disease Via Modulating the CXCR5/CXCL13 Axis

CRISPR/Cas9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

CRISPR/CAS9 Gene Editing of MIR155HG in Primary Human T Cells to Prevent Acute Graft-Versus-Host Disease

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

CXCR7 Reactivates ERK Signaling to Promote Resistance to EGFR Kinase Inhibitors in NSCLC

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

PRMT5 promotes STAT-1 mediated T cell inflammatory response and is a therapeutic target for acute graft-versus-host disease

20. A Novel Approach in the Treatment of Dystrophic Cardiomyopathy

577. Empower Multiplex CRISPR-Mediated Gene Manipulation with Self-Cleaving Ribozymes and tRNA

Suchergebnisse filtern